Trial
NCT02750254
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Washington University School of Medicine
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Fludarabine
Why stopped
Toxicity. Only enrolled patients in phase I portion of trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-20